Vireo Growth Total Depreciation and Amortization - Cash Flow 2023-2025 | VREOF

Vireo Growth total depreciation and amortization - cash flow from 2023 to 2025. Total depreciation and amortization - cash flow can be defined as the total amount of depreciation and amortization listed on the Cash Flows Statement

Vireo Growth Total Depreciation and Amortization - Cash Flow 2023-2025 | VREOF

Vireo Growth total depreciation and amortization - cash flow from 2023 to 2025. Total depreciation and amortization - cash flow can be defined as the total amount of depreciation and amortization listed on the Cash Flows Statement
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$219.8B
Boston Scientific (BSX)$156.6B
Stryker (SYK)$152.9B
EssilorLuxottica (ESLOY)$137.9B
Medtronic (MDT)$118B
Lonza Group Ag (LZAGY)$49.3B
Haleon (HLN)$43.6B
ResMed (RMD)$40.1B
GE HealthCare Technologies (GEHC)$35.6B
Agilent Technologies (A)$34B
Terumo (TRUMY)$25.6B
Koninklijke Philips (PHG)$24.7B
Insulet (PODD)$20.6B
Zimmer Biomet Holdings (ZBH)$19B
Baxter (BAX)$14.6B
Smith & Nephew SNATS (SNN)$13.7B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$6.9B
Lantheus Holdings (LNTH)$5B
Perrigo (PRGO)$3.9B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.1B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.8B
AtriCure (ATRC)$1.6B
Acuren (TIC)$1.4B